NEWS
View news from our Featured Companies.
Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia
- 108 patients have completed 1-year of treatment - - Brilaroxazine is generally well tolerated to date in patients with acute and stable schizophrenia - - Topline data from 1-year open-label extension (OLE) trial now expected in December 2024 - CUPERTINO, Calif.,...
Greenfire Announces Deferred Consideration of the New Shareholder Rights Plan by the Toronto Stock Exchange; Plan Remains in Effect
Calgary, Alberta--(November 11, 2024) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company"), a Calgary-based energy company focused on the production and development of thermal energy resources from the Athabasca region of Alberta, Canada...
Precision Optics Corporation Schedules First Quarter of Fiscal Year 2025 Conference Call for November 14, 2024
GARDNER, Mass., Nov. 11, 2024 -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference...
Modular Medical Proudly Sponsors the Inaugural Achieving Diabetes Equity in Practice Today (ADEPT) Conference
SAN DIEGO, CA / November 11, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly...
ARIANNE PHOSPHATE PROVIDES CLARIFICATION TO PRIOR NEWS RELEASE
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTCQX (USA) SAGUENAY, QC, Nov. 8, 2024 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTCQX: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing the Lac à Paul project...
Registration Is Now Open For Tribe Public’s Webinar Event “Tailoring GLP-1 Weight Loss Treatments: Innovative Approaches To Personalized Dosing” Featuring Modular Medical CEO On Monday, November 11, 2024
Meet with Modular Medical CEO, Jeb BesserObesity is linked to 30% to 53% of new diabetes cases in the U.S. every year, per research in the Journal of the American Heart AssociationAbout half of all patients prescribed a GLP-1 drug for weight loss discontinued after...
Kiora Pharmaceuticals Reports Third Quarter Results; Retinal Disease Pipeline Advancing Two Phase 2 Studies
Encinitas, California--(November 8, 2024) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced third quarter 2024 financial results and provided an update on its pipeline of therapeutics for the treatment of retinal diseases. Key...
LiqTech International to Discuss Third Quarter 2024 Results on Thursday, November 14, 2024
Management to Host Conference Call on Thursday, November 14, 2024, at 9:00 a.m. ET BALLERUP, Denmark, Nov. 7, 2024 -- LiqTech International, Inc. (NASDAQ: LIQT), a high-tech filtration company that manufactures and markets highly specialized filtration products and...
LiqTech Establishes a Joint Venture in China for Marine Water Treatment Market
BALLERUP, Denmark, Nov. 7, 2024 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and systems, and Jiangsu Marine Equipment Co., Ltd. ("JiTRI"), have established a joint...
CADRENAL THERAPEUTICS PROVIDES THIRD-QUARTER CORPORATE UPDATE
PONTE VEDRA, Fla., Nov. 7, 2024 -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD) (the "Company" or "Cadrenal"), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) designed to provide safer and superior anticoagulation for...
ChromaDex’s Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide
National rollout provides enhanced accessibility to Niagen IV, a significant advancement in NAD+ IV therapy LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, today...
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024
Conference Call Scheduled for Thursday, November 14, 2024 at 9:00 AM ETPORTLAND, Maine, Nov. 07, 2024 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven...
Modular Medical Announces Results from a Successful GLP-1 Proof of Concept Study
-Study showed more potent weight loss and blood glucose control with the addition of a mealtime bolus of a rapid acting GLP-1 to basal delivery- Observed weight loss was 17% at 28 days, a 25% improvement over GLP-1 delivered as basal alone-Findings suggest that pump...
PolyPid to Participate in the Craig-Hallum 15th Annual Alpha Select Conference
PETACH TIKVA, Israel, Nov. 07, 2024 -- PolyPid Ltd. (Nasdaq: PYPD), ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that the Company's management will participate in investor meetings at the...
InfuSystem Reports Third Quarter 2024 Financial Results
Record Net Revenues of $35.3 million Representing 11% Growth from the Prior Year Net income of $1.8 million, an increase of 162% Adjusted EBITDA (non-GAAP) margin expanded by 2.8% to 22% Reaffirms Full-Year 2024 Guidance ROCHESTER HILLS, Mich. - InfuSystem Holdings,...
Greenfire Resources Ltd. Files Injunction Following Cease Trade of Rights Plan; Proceeds with Strategic Review and Adopts New Shareholder Rights Plan
Calgary, Alberta--(November 6, 2024) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company"), a Calgary-based energy company focused on the production and development of thermal energy resources from the Athabasca region of Alberta, Canada has...
Mogo Reports Results for Q3 2024 and Expects Positive Adjusted Net Income for 2025
Raises 2024 Adjusted EBITDA1,2 guidance & introduces 2025 Adjusted EBITDA guidance of $10 to $12 million Quarterly payments volume increased 23% year-over-year to a record $3.0 billion AUM Increased 22% year-over-year to $409 million Adjusted EBITDA increased...
Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024
CUPERTINO, Calif., Nov. 06, 2024 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
SenesTech to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Nov. 5, 2024 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its third quarter 2024, ended September 30, 2024, after the market close on...
NeurAxis to Host Third Quarter 2024 Results and Business Update Call on Tuesday, November 12, 2024
CARMEL, Ind., Nov. 05, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will report summarized...
NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable Market
Clearance expands indication for use from 11-18 year olds to 8-21 year olds; and from 3 devices, not to exceed 4 weeks, to 1 device per week for 4 weeksCARMEL, Ind., Nov. 04, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical...
IRADIMED CORPORATION Named to Fortune’s 100 Fastest Growing Companies List for 2024
WINTER SPRINGS, Fla., Nov. 04, 2024 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) was recently named one of Fortune's 100 Fastest Growing Companies for 2024. Iradimed is a leader in the development of innovative magnetic resonance imaging ("MRI") medical...
Greenfire Resources Provides Update on Strategic Review Process, Reserves Report Timeline and Announces Date for Q3 2024 Results and Conference Call
Calgary, Alberta--(November 4, 2024) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company"), a Calgary-based energy company focused on the production and development of thermal energy resources from the Athabasca region of Alberta,...
Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds
PONTE VEDRA, Fla., Nov. 1, 2024 -- Cadrenal Therapeutics, Inc., ("Cadrenal" or the "Company") (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) for certain rare medical conditions,...
S&W Announces Fiscal 2024 Financial Results
Company to host conference call and webcast today at 11:00 a.m. Eastern time to discuss the results LONGMONT, Colo., Nov. 1, 2024 -- S&W Seed Company (Nasdaq: SANW) today announced financial results for the fiscal year ended June 30, 2024. Financial Highlights...